190 related articles for article (PubMed ID: 30425008)
1. The use of goal attainment scaling during clinical medication review in older persons with polypharmacy.
Verdoorn S; Blom J; Vogelzang T; Kwint HF; Gussekloo J; Bouvy ML
Res Social Adm Pharm; 2019 Oct; 15(10):1259-1265. PubMed ID: 30425008
[TBL] [Abstract][Full Text] [Related]
2. DREAMeR: Drug use Reconsidered in the Elderly using goal Attainment scales during Medication Review; study protocol of a randomised controlled trial.
Verdoorn S; Kwint HF; Blom J; Gussekloo J; Bouvy ML
BMC Geriatr; 2018 Aug; 18(1):190. PubMed ID: 30143003
[TBL] [Abstract][Full Text] [Related]
3. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study).
Verdoorn S; Kwint HF; Blom JW; Gussekloo J; Bouvy ML
PLoS Med; 2019 May; 16(5):e1002798. PubMed ID: 31067214
[TBL] [Abstract][Full Text] [Related]
4. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
5. [Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study in Dutch community pharmacies].
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Ned Tijdschr Geneeskd; 2016; 160():D439. PubMed ID: 27924735
[TBL] [Abstract][Full Text] [Related]
6. Drug-related problems identified during medication review before and after the introduction of a clinical decision support system.
Verdoorn S; Kwint HF; Hoogland P; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2018 Apr; 43(2):224-231. PubMed ID: 28971492
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility and cost-effectiveness analysis of a clinical medication review focused on personal goals in older persons with polypharmacy compared to usual care: Economic evaluation of the DREAMeR study.
Verdoorn S; van de Pol J; Hövels AM; Kwint HF; Blom JW; Gussekloo J; Bouvy ML
Br J Clin Pharmacol; 2021 Feb; 87(2):588-597. PubMed ID: 32520439
[TBL] [Abstract][Full Text] [Related]
8. Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder.
Geurts MM; Stewart RE; Brouwers JR; de Graeff PA; de Gier JJ
Int J Clin Pharm; 2016 Aug; 38(4):808-15. PubMed ID: 27052212
[TBL] [Abstract][Full Text] [Related]
9. Drug-related problems among community-dwelling older adults in mainland China.
Yang J; Meng L; Liu Y; Lv L; Sun S; Long R; Shan X; Song J; Qiu F
Int J Clin Pharm; 2018 Apr; 40(2):368-375. PubMed ID: 29340850
[TBL] [Abstract][Full Text] [Related]
10. Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study.
Szilvay A; Somogyi O; Meskó A; Zelkó R; Hankó B
BMC Health Serv Res; 2019 May; 19(1):282. PubMed ID: 31053135
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of drug-related problems in older polypharmacy primary care patients.
Kovačević SV; Miljković B; Ćulafić M; Kovačević M; Golubović B; Jovanović M; Vučićević K; de Gier JJ
J Eval Clin Pract; 2017 Aug; 23(4):860-865. PubMed ID: 28370742
[TBL] [Abstract][Full Text] [Related]
12. The contribution of patient interviews to the identification of drug-related problems in home medication review.
Kwint HF; Faber A; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2012 Dec; 37(6):674-80. PubMed ID: 22861493
[TBL] [Abstract][Full Text] [Related]
13. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial.
Vinks TH; Egberts TC; de Lange TM; de Koning FH
Drugs Aging; 2009; 26(2):123-33. PubMed ID: 19220069
[TBL] [Abstract][Full Text] [Related]
14. Completeness of medication reviews provided by community pharmacists.
Kwint HF; Faber A; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2014 Jun; 39(3):248-52. PubMed ID: 24521180
[TBL] [Abstract][Full Text] [Related]
15. Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program.
Krähenbühl JM; Decollogny A; Bugnon O
Pharm World Sci; 2008 Dec; 30(6):816-22. PubMed ID: 18551382
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation.
Stuhec M; Gorenc K; Zelko E
BMC Health Serv Res; 2019 Feb; 19(1):118. PubMed ID: 30760276
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive medication reviews for elderly patients: findings and recommendations to physicians.
Leikola SN; Virolainen J; Tuomainen L; Tuominen RK; Airaksinen MS
J Am Pharm Assoc (2003); 2012; 52(5):630-3. PubMed ID: 23023843
[TBL] [Abstract][Full Text] [Related]
18. Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria.
Verdoorn S; Kwint HF; Faber A; Gussekloo J; Bouvy ML
Eur J Clin Pharmacol; 2015 Oct; 71(10):1255-62. PubMed ID: 26249851
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential drug-related problems in the elderly: the role of the community pharmacist.
Vinks TH; de Koning FH; de Lange TM; Egberts TC
Pharm World Sci; 2006 Feb; 28(1):33-8. PubMed ID: 16703267
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies.
Quintana-Bárcena P; Lord A; Lizotte A; Berbiche D; Lalonde L
J Manag Care Spec Pharm; 2018 Feb; 24(2):173-181. PubMed ID: 29384023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
